Heard of BLACKBOX®? It's Panadea now!
The BLACKBOX® ELISA kits developed at the Bernhard-Nocht Institute for Tropical Medicine, in Hamburg, Germany, have been transferred to us and rebranded as Panadea. These kits, with their high performance characteristics as seen in several comparative studies and population seroprevalence studies, are now available from us with the same high quality that they're known for, in the same hands that previously developed and supplied them.
IgG and IgM kits for Zika, Crimean Congo Hemorrhagic Fever, SARS-CoV-2 and Lassa Fever viruses now commercial.
"We're excited to be able to offer these products, which have been highly sought after in the relevant research fields, to customers from around the world."
- Dr. Yang Liu, CEO Panadea Diagnostics GmbH
The BLACKBOX® ELISA products have been used by scientists in over 20 countries worldwide. Following increased demand, these products, covering the detection of the immunoglobulins IgG and IgM in the four viral diseases Zika, Crimean Congo Hemorrhagic Fever, SARS-CoV-2 and Lassa Fever, have been transferred to Panadea in order to secure the delivery chain and ensure that existing and new customers can receive these kits into the future.
No longer a black box.
We value our customers feedback. With the rebranding of BLACKBOX® to Panadea, we promise to our customers to continue with the high level of product transparency and detailed customer support that has driven much of the trust in the BLACKBOX® products.
The new box, now white with our Panadea branding, emphasises our commitment to this ideal and to the provision of these high quality kits to our customers.
Together with this change, we have modified the kit box of these products to a much smaller footprint, occupying less than half of the previous box volume. With this change comes more efficient, eco friendly shipping and easier storage at the customers end.